Sino Biopharmaceutical Ltd - Company Profile

Powered by

All the sales intelligence you need on Sino Biopharmaceutical Ltd in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Sino Biopharmaceutical Ltd fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Sino Biopharmaceutical Ltd.

Back to companies

Sino Biopharmaceutical Ltd: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Sino Biopharmaceutical Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Sino Biopharmaceutical Ltd's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Tse, Eric S Y

Chief Executive Officer; Director Executive Board Since: 2022 Age: 29

Mr. Tse, Eric S Y has been the Chief Executive Officer and Director of the company since 2022. Prior to this, he served as the Chief Executive Officer of Liepin North America. Currently, he also serves as the Chairman of CT Tianqing, the Chairman of Beijing Tide and a Director of NJCTT.

Read Hide full bio of Tse, Eric S Y

Theresa Tse

Chairwoman Executive Board Since: 2015 Age: 32

Ms. Tse Theresa has been the Chairwoman of the company since 2015. Prior to this, she worked in the investment, finance and business development departments of various companies. Currently, she also serves as a Director of the company’s subsidiary CT Tianqing and the vice chairwoman of Beijing Tide.

Read Hide full bio of Theresa Tse

Sean Chen

Chief Strategy Officer Senior Management Age: 46

Mr. Sean Chen is the Chief Strategy Officer of the company. Prior to this, General Manager of respiratory, immunology and GI units of AstraZeneca China. Previously, he also served as the Head of BD & corporate strategy of Takeda China. He also served in various roles at Novartis and McKinsey.

Read Hide full bio of Sean Chen

Kang Xiaoyan

Chief Medical Officer Senior Management Since: 2026

Ms. Kang Xiaoyan has been the Chief Medical Officer of the company since April 2026. Prior to this, she served as the Executive Deputy General Manager of the Clinical R&D Centre and the Chief Medical Officer for Oncology of the company.

Read Hide full bio of Kang Xiaoyan

Tse Ping

Senior Vice Chairman Executive Board Since: 2020 Age: 73
Gain a 360-degree view of Sino Biopharmaceutical Ltd and make more informed decisions for your business Gain a 360-degree view of Sino Biopharmaceutical Ltd and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer